97色婷婷-风间由美在线观看-六月婷婷综合-欧美在线视频一区-欧美日韩亚洲一区二区三区-色噜噜在线-午夜黄色大片-丰满人妻一区二区三区52-992av-在线观看aa-欧美乱论视频-黄色大片久久-亚洲伦理影院-av网站免费在线-男女考妣视频-青草一区-欧美日韩在线第一页-亚洲毛片一区二区三区-av成人免费网站-在线视频 91-丝袜美腿影音先锋-野花视频免费在线观看-婷婷的五月-国产91精品网站-岛国激情片

D10977

黃芪甲苷

產(chǎn)品編號(hào): D10977 一鍵復(fù)制產(chǎn)品信息
中文名稱: 黃芪甲苷
英文名稱: Astragaloside IV
CAS號(hào): 84687-43-4
分子式: C41H68O14
分子量: 784.97
MDL號(hào): MFCD16036240
外觀與形狀:
熔點(diǎn): 295-296?°C (lit.)
沸點(diǎn): 895.7±65.0 °C at 760 mmHg
密度: 1.39
閃點(diǎn): 895.7±65.0 °C at 760 mmHg
穩(wěn)定性:
SMILES: C[C@@]12C[C@H](O)[C@H]([C@]3(CC[C@@H](C(O)(C)C)O3)C)[C@@]1(C)CC[C@@]13C[C@]41CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)[C@@H]4[C@H](C[C@@H]23)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1
溶解性:
產(chǎn)品描述:
儲(chǔ)存條件: Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
信號(hào)詞: Warning
危害聲明: H315-H319-H335
警示性聲明: P261-P305+P351+P338
安全說明: S22-S24/25
產(chǎn)品編號(hào)
批號(hào)
下載質(zhì)量認(rèn)證證書
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

用本工具協(xié)助配置特定濃度的溶液,使用的計(jì)算公式為:
開始濃度 x 開始體積 = 最終濃度 x 最終體積

稀釋公式

稀釋公式一般簡(jiǎn)略地表示為:C1V1 = C2V2 ( 輸入 輸出 )

連續(xù)稀釋計(jì)算器方程

  • 連續(xù)稀釋

  • 初始濃度:
  • 稀釋倍數(shù):
  • 計(jì)算結(jié)果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular weight calculator
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol
Animal experiment calculation converter
第一步:請(qǐng)輸入基本實(shí)驗(yàn)信息(考慮到實(shí)驗(yàn)過程中的損耗,建議多配一只動(dòng)物的藥量)
第二步:請(qǐng)輸入動(dòng)物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請(qǐng)聯(lián)系SparkJade為您提供正確的澄清溶液配方)
+
+
+

計(jì)算結(jié)果:

工作液濃度 mg/ml;

DMSO母液配制方法 mg 藥物溶于 μL DMSO溶液(母液濃度 mg/mL,

體內(nèi)配方配制方法μL DMSO母液,加入 μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入 μL ddH2O,混勻澄清。

1. 首先保證母液是澄清的;
           2. 一定要按照順序依次將溶劑加入,進(jìn)行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。

黃芪甲苷

黃芪甲苷
ASTRAGALOSIDE;9,19-CYCLOLANOSTANE-BETA-D-GLUCOPYRANOSIDE;ASTRAGALOSIDE IV;Astrasieversianin XIV;β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-;Astragaloside Ⅳ;ASTRAGALOSIDE IV(P);ASTRAGALOSIDE IV(RG);beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl;Astragalus P.E;Astragalus extract;Astragalus Polysaccharides;CH83947;CH90651;cyclosieversioside F;cyclosiversioside F;KT Astragaloside IV;1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,b-D-glucopyranoside deriv.;9,19-Cyclolanostane, b-D-glucopyranoside deriv.;Astraversianin XIV;Astragalus Root Extract;AstragalosideIV;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;(3β,6α,16β,20R,24S)-20,24-Epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl β-D-glucopyranoside (ACI);1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv. (ZCI);9,19-Cyclolanostane, β-D-glucopyranoside deriv. (ZCI);Astragaloside Iv,(S);84687-43-4;FT-0686574;83207-58-3;NS00018369;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;2-Hydroxy-1-(5-(1-hydroxy-1-methylethyl)-2-methyltetrahydro-2-furanyl)-3a,6,6,12a-tetramethyl-7-(pentopyranosyloxy)tetradecahydro-1H-cyclopenta[a]cyclopropa[e]phenanthren-5-yl hexopyranoside;NSC650944;SY067110;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;16,25-Dihydroxy-3-(pentopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl hexopyranoside;MFCD16036240;2-[hydroxy-[5-(1-hydroxy-1-methyl-ethyl)-2-methyl-tetrahydrofuran-2-yl]-tetramethyl-(3,4,5-trihydroxytetrahydropyran-2-yl)oxy-[?]yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;DTXSID70868831;1ST40060;C17799;(2R,3R,4S,5S,6R)-2-[[(1S,3R,8R,9S,11S,12S,14S,15R,16R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;HMS3885E12;ASTRAGALOSIDE IV (CONSTITUENT OF ASTRAGALUS) [DSC];CHEBI:65457;Astragaloside IV, United States Pharmacopeia (USP) Reference Stan...

   

最優(yōu)采購(gòu)方案
專業(yè)包裝 正品保障
急速物流  安全配送
品類齊全  輕松購(gòu)物